Codiak racks up over $80 mln, appoints Williams as CEO and president
Codiak BioSciences Inc, which is focused on using exosomes to treat and diagnose cancer and other diseases, has secured over $80 million in committed funding. Codiak's investors include Fidelity Management and Research Company, the Alaska Permanent Fund and Alexandria Venture Investments. In addition to the funding, Codiak has appointed Dr. Douglas E. Williams as its founding president and chief executive officer. Previously, Williams worked at Biogen where he served as executive vice president of research and development.
17 November 2015•7 mins read
